drugset / Trial / NCT02581826
Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation
RandomizedCrossoverQuadruple-blindTreatment
Summary
The objectives of the present study aims to evaluate the safety and efficacy of Silodosin in a population of patients wih Premature Ejaculation (PE). Coupled with efficient diagnosis, it is hoped that the newer agent will improve the quality of life for patients who suffer from Premature Ejaculation (PE).
Timeline
- Start
- 2013-10
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Silodosin | Unknown | 4 mg | Oral |